Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial

Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial

BackgroundThe ability to quantify an immune response after vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is essential. This study assessed the clinical utility of the quantitative Roche Elecsys® Anti-SARS-CoV-2 S assay (ACOV2S) using samples from the 2019-nCoV vacc...

Full description

Bibliographic Details
Main Authors: Simon Jochum, Imke Kirste, Sayuri Hortsch, Veit Peter Grunert, Holly Legault, Udo Eichenlaub, Basel Kashlan, Rolando Pajon
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Immunology
Subjects:
SARS-CoV-2
COVID-19
quantitative serology
vaccination
ELISA
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.798117/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.798117/full

Similar Items